Improper phlebotomy practice is among one of the most important, and more so, overlooked issues in laboratory medicine. Lab practices involving phlebotomy are critical for diagnostic purposes as erroneous results from incorrect collection can result in potentially life threatening misdiagnoses or treatment routes. This pre-analytical error can result in misleading hyperkalemia and hypocalcemia illustrated in otherwise healthy patients. Improper order of draw can incur costs for both the patient and healthcare facility. Preventative measures must be employed to reduce such adverse events from reoccurring as this singular error can lead to a domino effect of continuous error if not recognized and investigated.
This past year I have been a student research associate at Cincinnati Children’s OT/PT department for Dr. Karen Harpster, PhD, OTR/L. I have reviewed various literature on upcoming therapeutic topics for many common diagnoses from infants to adolescents, which one of them in particular is cerebral palsy. CP is the most common physical disability in childhood. The purpose of my presentation is to underline the importance of early detection for cerebral palsy. Through extensive review, studies have shown that the most effective way to predict cerebral palsy is by conducting two neurological assessments (General Movements Assessment and the Hammersmith Infant Neurological Examination), along with electrophysiological and neuroimaging tests. This presentation outlines how and why clinicians should use these neurological assessments. In detecting cerebral palsy early on in infancy, early intervention can be integrated which can lead to an overall improvement in the quality of life in children with CP.
Scholarly research presented at the University of Cincinnati's 2017 PRaISE conference on Capnocytophaga infections during pregnancy. This poster includes background information, a case study, clinical presentation, lab workup, and treatment.
A 67-year-old female presented with an abnormal complete blood count (CBC) when arriving for an angiogram. An abnormal white blood cell (WBC) differential showed 17% blasts which led her physician to have a bone marrow biopsy performed. The bone marrow aspirate smear showed an increased number of blasts and the bone marrow core biopsy revealed 90% cellularity where normal precursors were replaced by blasts. Flow cytometry and chromosome analysis results were consistent with Acute Myelomonocytic Leukemia (AMML). The patient was placed on FLAG chemotherapy until a goal of 0.9-1.0x10^9/L absolute neutrophil count is achieved, at which time a catheter will be placed to address her cardiac comorbidities. Cardiac disease and AML comorbidities are a commonly encountered issue in oncology patients. Due to this patient’s history of cardiac disease, treating her AML is more complicated in order to ensure that chemotherapy does not worsen her cardiac complications.